DIGEST
The digest printed below was prepared by House Legislative Services. It constitutes no part of the
legislative instrument. The keyword, one-liner, abstract, and digest do not constitute part of the law
or proof or indicia of legislative intent. [R.S. 1:13(B) and 24:177(E)]
HB 250 Engrossed 2019 Regular Session Davis
Abstract: Requires residential treatment facilities licensed pursuant to the Behavioral Health
Services Provider Licensing Law to provide access to medication-assisted treatment for
patients with opioid use disorder.
Proposed law requires each residential treatment facility licensed pursuant to present law, R.S.
40:2151 et seq., which provides treatment for opioid use disorder to provide all of the following:
(1)Onsite access to at least one form of FDA-approved opioid agonist treatment.
(2)Access to at least one form of FDA-approved opioid antagonist treatment either onsite or by
referral.
Proposed law prohibits the La. Department of Health (LDH) from taking any action prior to Jan. 1,
2023, against a residential treatment facility licensed as of the effective date of proposed law for
failure to comply with proposed law.
Proposed law requires LDH to develop a monitoring mechanism to track and report on which
providers are complying with the requirements of proposed law.
Proposed law requires LDH to offer technical assistance to providers seeking to comply with the
requirements of proposed law.
Proposed law requires each provider subject to proposed law to furnish to LDH a report on or before
Jan. 1, 2021, which addresses its progress toward satisfying the requirements of proposed law.
Eff. Jan. 1, 2020.
(Amends R.S. 40:2156(B)(intro. para.) and (6) and 2159; Adds R.S. 40:2153(15))